H.R. 3772 · 116th Congress
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
- Stage
- In committee
- Sponsor
- Scott Peters
- Introduced
- 2019-07-16
- Latest action
- 2019-07-17 · Referred to the Subcommittee on Health.
Summary
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2020 and as adjusted based on a specified fee schedule factor in each year thereafter.